全文获取类型
收费全文 | 7031篇 |
免费 | 682篇 |
国内免费 | 358篇 |
专业分类
耳鼻咽喉 | 38篇 |
儿科学 | 74篇 |
妇产科学 | 168篇 |
基础医学 | 922篇 |
口腔科学 | 99篇 |
临床医学 | 847篇 |
内科学 | 1195篇 |
皮肤病学 | 66篇 |
神经病学 | 437篇 |
特种医学 | 293篇 |
外国民族医学 | 3篇 |
外科学 | 760篇 |
综合类 | 952篇 |
现状与发展 | 1篇 |
一般理论 | 2篇 |
预防医学 | 338篇 |
眼科学 | 147篇 |
药学 | 813篇 |
5篇 | |
中国医学 | 316篇 |
肿瘤学 | 595篇 |
出版年
2024年 | 29篇 |
2023年 | 117篇 |
2022年 | 293篇 |
2021年 | 375篇 |
2020年 | 300篇 |
2019年 | 279篇 |
2018年 | 278篇 |
2017年 | 223篇 |
2016年 | 182篇 |
2015年 | 351篇 |
2014年 | 398篇 |
2013年 | 350篇 |
2012年 | 567篇 |
2011年 | 581篇 |
2010年 | 327篇 |
2009年 | 248篇 |
2008年 | 334篇 |
2007年 | 326篇 |
2006年 | 361篇 |
2005年 | 420篇 |
2004年 | 219篇 |
2003年 | 199篇 |
2002年 | 159篇 |
2001年 | 115篇 |
2000年 | 137篇 |
1999年 | 143篇 |
1998年 | 70篇 |
1997年 | 70篇 |
1996年 | 57篇 |
1995年 | 54篇 |
1994年 | 60篇 |
1993年 | 25篇 |
1992年 | 56篇 |
1991年 | 54篇 |
1990年 | 41篇 |
1989年 | 43篇 |
1988年 | 32篇 |
1987年 | 32篇 |
1986年 | 17篇 |
1985年 | 19篇 |
1984年 | 18篇 |
1983年 | 6篇 |
1982年 | 10篇 |
1981年 | 7篇 |
1979年 | 10篇 |
1978年 | 16篇 |
1973年 | 10篇 |
1972年 | 6篇 |
1967年 | 7篇 |
1966年 | 5篇 |
排序方式: 共有8071条查询结果,搜索用时 15 毫秒
1.
AbstractBackground: This study aims to compare the effectiveness of inhaled prostacyclin or its analoguesversus nitric oxide (NO) in treating pulmonary hypertension (PH) after cardiac or pulmonary surgery remains unclear.Methods: PubMed, Cochrane, and Embase databases were searched for literature published prior to December 2019 using the following keywords: inhaled, nitric oxide, prostacyclin, iloprost, treprostinil, epoprostenol, Tyvaso, flolan, and pulmonary hypertension. Randomized controlled trials and multiple-armed prospective studies that evaluated inhaled NO versus prostacyclin (or analogues) in patients for perioperative and/or postoperative PH after either cardiac or pulmonary surgery were included. Retrospective studies, reviews, letters, comments, editorials, and case reports were excluded.Results: Seven studies with a total of 195 patients were included. No difference in the improvement of mean pulmonary arterial pressure (pooled difference in mean change= ?0.10, 95% CI: ?3.98 to 3.78, p?=?.959) or pulmonary vascular resistance (pooled standardized difference in mean change= ?0.27, 95% CI: ?0.60 to 0.05, p?=?.099) were found between the two treatments. Similarly, no difference was found in other outcomes between the two treatments or subgroup analysis.Conclusions: Inhaled prostacyclin (or analogues) was comparable to inhaled NO in treating PH after cardiac or pulmonary surgery.
- Key messages
This study compared the efficacy of inhaled prostacyclin or its analogues versus inhaled NO to treat PH after surgery. The two types of agent exhibited similar efficacy in managing MPAP, PVR, heart rate, and cardiac output was observed.
Inhaled prostacyclin may serve as an alternative treatment option for PH after cardiac or pulmonary surgery.
2.
3.
4.
5.
Chih-Ming Lin Pei-Chen Lee Sen-Wen Teng Tsung-Hsueh Lu I-Fang Mao Chung-Yi Li 《台湾医志》2004,103(4):297-301
BACKGROUND AND PURPOSE: Birth certificates are a major source of population-based data often used in maternal and child health research, but their value depends upon the level of accuracy of the data. The purpose of this study was to assess the validity of the birth registry data in Taiwan. METHODS: Obstetric records of a total of 2779 infants born at a municipal hospital in Taipei between 1995 and 1997 were abstracted and linked to the Taiwan Birth Registry (TBR). Concordance was presented by agreement percentages for various birth characteristics including gender, birth order, birth weight, and gestational age. Concordance was further assessed using Cohen's k and sensitivity/specificity for both birth weight and gestational age, with both variables categorized according to their customary definitions. RESULTS: Missing data for specific items in the TBR ranged from 0% (gender) to 1.6% (birth order). The birth registry accurately reported all 4 selected items, with the highest and lowest concordance percentage noted for gender (99.0%) and gestational age (88.3%), respectively. The level of agreement indicated by the Cohen's k statistic ranged from 0.92 to 0.96 for birth weight and gestational age when both variables were treated as categorical variables. CONCLUSIONS: The TBR showed a low rate of missing information and high levels of validity for the elements frequently used in maternal and child health research in Taiwan. 相似文献
6.
Joen-Rong sheu Chao-Hsin Lin Jih-Luan chung Che-Ming Teng Tur-Fu Huang 《Thrombosis research》1992,66(6):679-691
Triflavin, an Arg-Gly-Asp (RGD)-containing peptide, purified from snake venom of Trimeresurus flavoviridis, inhibits human platelet aggregation through the blockade of fibrinogen binding to fibrinogen receptors associated with glycoprotein IIb/IIIa complex. In this report, we examined the effect of triflavin on tumor cells (human hepatoma J-5)-induced platelet aggregation (TCIPA) of heparinized platelet-rich plasma (PRP). ADP-scavenger agents, apyrase (10 U/ml) and creatine phosphate (5 mM)/creatine phosphokinase (5 U/ml) did not inhibit TCIPA while hirudin (5u/ml) completely inhibited it. J-5 cells initially induced platelet aggregation, then blood coagulation occurred. J-5 cells concentration-dependently shortened the recalcification time of normal as well as Factor VIII, IX-deficient human plasmas, while it was inactive at shortening the recalcification time of Factor VII-deficient plasma, suggesting J-5 cells induced platelet aggregation through activation of extrinsic pathway, leading to thrombin formation as evidenced by the amidolytic activity on S-2238 by expressing tissue factor-like activity. Triflavin inhibited TCIPA in a dose-dependent manner (IC50, 0.02 μM). When compared on molar ratio, triflavin was approximately 30,000 times more potent than GRGDS (IC50,0.58 mM). On the other hand, GRGES showed no significant effect on TCIPA, even its concentration was raised to 4 mM. Additionally, the monoclonal antibodies, raised against glycoprotein IIb/IIIa complex (i.e., 7E3 and 10 E5) inhibited J-5 TCIPA. In conclusion, we suggest the inhibitory effect of triflavin on J-5 TCIPA may be chiefly mediated by the binding of triflavin to the fibrinogen receptor associated with glycoprotein IIb/IIIa complex on platelet surface membrane. 相似文献
7.
本文阐述了1990年-1993年间沈阳口岸入境人员传染病监测工作的基本情况,在对6503名归国人员和2146名外籍人员进行传染病监测体检中,发现HIV感染者41人、隐性梅毒患者1人、开放性肺结核患者1人。 相似文献
8.
复式脉冲低能量ESWL治疗肾结石769例报告 总被引:3,自引:0,他引:3
目的探讨复式脉冲HB-V型低能量体外冲击波碎石机治疗肾结石的治疗效果.方法采用复式脉冲HB-ESWL-VG型低能量碎石机治疗直径<2.0 cm的各类肾结石769例,治疗工作电压3~9 kV,平均冲击次数2 300次.结果肾盏结石总粉碎率为97.4%,其中上中盏结石复打率为13.1%,术后3个月排净率为89.4%,下盏结石复打率为17.3%,排净率为81.5%;肾盂结石粉碎率为98.3%,复打率为6.1%,术后3个月排净率为93.0%.结论复式脉冲低能量ESWL治疗肾结石具有治疗成功率高、复打率低、无严重并发症、副作用少之优点. 相似文献
9.
Here are reported 83 cases with pelvic congestion syndrome after tubal ligation. Radionuclide 113m in blood-pool scanning was found to be a valuable method in detecting this syndrome in 72 cases who were proved by operation with a correct diagnosis rate of 98.6%. The mild cases received non-operative treatment. The relationship between the modalities of tubal ligation and this syndrome was discussed and preventive measures suggested. 相似文献
10.
Chien-Huang Lin Feng-Nien Ko Hisahi Ishii Tsutomu Ishikawa Ih-Sheng Chen Che-Ming Teng H.-P. Kuo 《Naunyn-Schmiedeberg's archives of pharmacology》1997,355(2):210-216
We investigated the effects of a novel platelet-activating factor (PAF) receptor antagonist, CIS-19 [cis-2-(3, 4-dimethoxyphenyl)-6-isopropoxy-7-methoxy-1-(N-methylformamido)-1,
2, 3, 4-tetrahydronaphthalene], on PAF-, histamine-, substance P- and antigen-induced bronchoconstriction and microvascular
leakage, as well as PAF- and antigen-induced bronchial hyperreactivity to methacholine in urethane-anesthetized guinea-pigs.
Administration of CIS-19 (0.5–5 mg/kg, i.v.) inhibited the increase in lung resistance induced by PAF (30 ng/kg, i.v.) in
a dose-dependent manner, but failed to inhibit the increase induced by histamine (30 μg/kg, i.v.) or substance P (6.5 μg/kg,
i.v.). CIS-19 (5 mg/kg, i.v.) did not inhibit the increase in lung resistance induced by ovalbumin (2 mg/kg, i.v.) in actively
sensitized guinea-pigs. PAF (30 ng/kg, i.v.)-induced microvascular leakage, measured by the extravasation of Evans blue dye,
was dose-dependently inhibited by CIS-19 (0.5–5 mg/kg, i.v.) in the trachea, main bronchi and intrapulmonary airways, but
it did not affect histamine (30 μg/kg, i.v.)- or substance P (6.5 μg/kg, i.v.)-induced microvascular leakage at all airway
levels. CIS-19 (2.5 and 5 mg/kg) did not affect ovalbumin (2 mg/kg, i.v.)-induced microvascular leakage in all airway levels
in actively sensitized guinea-pigs. CIS-19 (2.5 and 5 mg/kg, i.v.) significantly inhibited PAF-induced enhancement of the
bronchial response to methacholine, but had no effect on ovalbumin (0.05 mg/kg, i.v.)-induced bronchial hyperreactivity in
actively sensitized guinea-pigs. It is concluded that CIS-19 is a potent PAF receptor antagonist which inhibits PAF- but not
antigen-induced bronchoconstriction, microvascular leakage and bronchial hyperreactivity. These results suggest that PAF plays
little or no role in early airway responses following antigen challenge.
Received: 29 April 1996 / Accepted: 10 October 1996 相似文献